Head-to-head · free

Elevance Health Inc. vs Helus Pharma Inc.

ELV vs HELP — return on capital, cash generation, margins and balance sheet side by side.

ELV

1 / 1

measures where ELV leads

HELP

0 / 1

measures where HELP leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureELV · FY2025HELP
Revenue$199.1B—
Net income$5.7B—
Revenue growth (yearly, multi-year)9.5%—
Free cash flow$3.2B—
Free cash flow margin1.6%—
Net cash / (debt)——
ROIC——
Return on equity13.3%-84.5%
Gross margin——
Operating margin——
Net debt / EBITDA—1.10x

Figures are as reported by each company; latest fiscal year shown.

Where Elevance Health Inc.'s cash went (FY2025)

Capital spending
$1.1B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full ELV profile →

Where Helus Pharma Inc.'s cash went

Not reported yet.

Full HELP profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons